Eli Lilly & Co. (LLY) Tops Q2 EPS by 6c; Boosts FY12 EPS Outlook
Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $0.83, $0.06 better than ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
